Bora Pharmaceuticals Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	5,077	5,829	3,053	3,281	910.75
Short-Term Investments	38.37	67.86	342.63	247.62	-
Trading Asset Securities	20.28	20.28	-	-	-
Cash & Short-Term Investments	5,136	5,917	3,396	3,529	910.75
Cash Growth	-13.21%	74.25%	-3.77%	287.48%	35.94%
Accounts Receivable	9,260	10,482	4,028	6,120	824.77
Other Receivables	344.91	766.08	82.61	286.38	33.23
Receivables	9,604	11,248	4,111	6,407	858.01
Inventory	3,410	5,502	2,157	1,991	928.64
Prepaid Expenses	675.46	591	801.43	242.47	63.07
Other Current Assets	511.69	118.63	138.63	71.58	31.87
Total Current Assets	19,338	23,377	10,604	12,241	2,792
Property, Plant & Equipment	11,183	12,510	7,494	7,300	4,067
Long-Term Investments	5,929	236.33	21.26	62.03	-
Goodwill	2,664	3,618	3,010	983.59	-
Other Intangible Assets	3,580	3,920	2,665	1,164	171.05
Long-Term Deferred Tax Assets	1,170	1,190	1,045	829.64	243.78
Other Long-Term Assets	849.81	657.62	294.85	181.01	98.65
Total Assets	44,714	45,510	25,134	22,761	7,372
Accounts Payable	925.1	792.34	380.45	454.74	235.81
Accrued Expenses	111.46	132.63	30.86	29.33	321.24
Short-Term Debt	3,950	2,598	767.51	2,161	645.48
Current Portion of Long-Term Debt	1,691	1,189	630.5	725.63	222.09
Current Portion of Leases	80.62	116.6	106.04	75.31	17.54
Current Income Taxes Payable	321.05	484.33	987.43	238.65	50.58
Current Unearned Revenue	262.52	245.6	224.6	85.69	20.47
Other Current Liabilities	5,979	8,250	5,102	6,725	327.91
Total Current Liabilities	13,321	13,808	8,229	10,496	1,841
Long-Term Debt	11,796	14,324	2,724	4,037	1,028
Long-Term Leases	708.9	745.96	763.33	596.88	305.97
Long-Term Unearned Revenue	88.87	-	-	4.18	-
Pension & Post-Retirement Benefits	99.39	129.04	115.36	136.41	136.28
Long-Term Deferred Tax Liabilities	988.55	1,256	783.9	742.85	609.77
Other Long-Term Liabilities	239.08	323.59	753.09	1,608	298.57
Total Liabilities	27,242	30,586	13,368	17,621	4,220
Common Stock	1,274	1,031	1,014	753.82	684.12
Additional Paid-In Capital	6,056	4,408	3,318	1,236	1,026
Retained Earnings	8,346	7,020	4,729	2,549	1,466
Treasury Stock	-134.29	-43.18	-50.97	-53.09	-
Comprehensive Income & Other	-159.75	362.83	74.66	42.2	-23.26
Total Common Equity	15,381	12,779	9,085	4,528	3,153
Minority Interest	2,091	2,144	2,681	612.13	-
Shareholders' Equity	17,472	14,923	11,766	5,140	3,153
Total Liabilities & Equity	44,714	45,510	25,134	22,761	7,372
Total Debt	18,227	18,973	4,991	7,596	2,219
Net Cash (Debt)	-13,091	-13,056	-1,595	-4,067	-1,308
Net Cash Per Share	-69.41	-92.49	-12.84	-34.34	-11.20
Filing Date Shares Outstanding	126.99	123.39	121.33	117.01	117.32
Total Common Shares Outstanding	126.99	123.39	121.33	117.01	117.32
Working Capital	6,017	9,569	2,375	1,745	951.22
Book Value Per Share	121.12	103.57	74.88	38.70	26.87
Tangible Book Value	9,137	5,241	3,410	2,381	2,981
Tangible Book Value Per Share	71.95	42.47	28.10	20.35	25.41
Land	3,758	3,824	3,424	3,397	1,984
Buildings	7,289	7,963	1,945	1,905	1,393
Machinery	3,870	6,113	2,814	2,390	859.79
Construction In Progress	809.38	527.38	115.84	76.72	11.73
Leasehold Improvements	-	-	-	205.29	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.